Clinical & Diagnostic
-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...
May 19, 2025 | News
Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies ...
May 15, 2025 | News
Funding is part of the call for proposals "Innovations in Biotherapies and Bioproduction," coordinated by the Health Innovation Agency under Fra...
May 14, 2025 | News
The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstru...
May 14, 2025 | News
New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma BD (Becton...
May 14, 2025 | News
Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used w...
May 09, 2025 | News
Conducted under U.S. FDA-cleared IND– Plans for Phase 2 initiation in Q3 2025 and expansion into Peyronie's disease Connext, a clinical s...
May 09, 2025 | News
Vision health is emerging as a critical but under-addressed component of public health in Asia Pacific. In a region where populations are rapidly ageing an...
May 09, 2025 | Expert Insight
TiumBio (KRX: 321550.KQ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare a...
May 08, 2025 | News
Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), ...
May 07, 2025 | News
S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food...
May 01, 2025 | News
Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeu...
April 30, 2025 | News
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has re...
April 28, 2025 | News
Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed inspection by Taiwan Food and Dr...
April 25, 2025 | News
Most Read
Bio Jobs
News
Editor Picks